Pfizer (US): Independent Grants Program – Appropriate immunisations in adult patients with immune-mediated inflammatory conditions

Pfizer, under the independent grants for learning and change programme, invites proposals for its call on appropriate immunisations in adult patients with immune-mediated inflammatory conditions. This supports education and quality improvement programmes that focus on ensuring that adult patients with immune-mediated inflammatory conditions, specifically rheumatoid arthritis, spondyloarthritis and inflammatory bowel disease, are receiving appropriate vaccinations, as determined by their age, gender and specific clinical risk information such as age and the use of concomitant therapies.

Two categories of support are available:

  • category 1 – grant support available to enhance or expand existing immunisation activities;
  • category 2 – grant support to implement new immunisation initiatives.


The total available budget is USD $750,000 (approx. AUD $1.016M)


Applicant organisations must be based in Australia, New Zealand, and Europe, including Israel, Russia and Turkey.

The following types of institutions may apply:

  • medical, nursing, allied health and pharmacy professional schools;
  • healthcare institutions, both large and small; professional associations;
  • government agencies;
  • patient organisations, and other entities with a mission related to healthcare improvement.

Collaborations within and between different organisations are encouraged.

Submission Requirements & Due Date

Further Information

Need Help?

This entry was posted in Engineering, Computer & Mathematical Sciences, Funding by Award Type, Health & Medical Sciences, Sciences. Bookmark the permalink.

Comments are closed.